HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

J Zheng Selected Research

Giant Cell Carcinoma

1/2001Identification of metastasis associated gene G3BP by differential display in human cancer cell sublines with different metastatic potentials G3BP as highly expressed in non-metastatic.
12/2000[Regulatory effect of antisense VEGF121 cDNA transfection on angiogenesis and metastasis of human lung giant cell carcinoma].
10/2000[Inhibition of growth and metastasis of human giant cell carcinoma of the lung by transfection of antisense VEGF121 cDNA].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


J Zheng Research Topics

Disease

39Neoplasms (Cancer)
11/2021 - 01/2000
14Hypoxia (Hypoxemia)
01/2020 - 04/2001
12Neoplasm Metastasis (Metastasis)
11/2021 - 10/2000
12Infections
12/2019 - 05/2001
7Lymphatic Metastasis
01/2021 - 04/2001
7Carcinoma (Carcinomatosis)
10/2017 - 01/2000
5Inflammation (Inflammations)
01/2022 - 01/2005
5Insulin Resistance
01/2017 - 11/2007
5Shock
09/2014 - 05/2009
4Psoriasis (Pustulosis Palmaris et Plantaris)
01/2022 - 01/2017
4Body Weight (Weight, Body)
12/2021 - 03/2001
4Obesity
06/2020 - 02/2012
4Glioma (Gliomas)
06/2020 - 04/2002
4Carcinogenesis
08/2019 - 04/2002
4Lung Neoplasms (Lung Cancer)
03/2018 - 04/2001
4Cough
01/2018 - 01/2008
4Asthma (Bronchial Asthma)
01/2018 - 02/2006
4Type 2 Diabetes Mellitus (MODY)
05/2015 - 11/2007
4Dementia (Dementias)
10/2005 - 04/2000
3Wounds and Injuries (Trauma)
05/2022 - 12/2000
3Necrosis
01/2022 - 01/2019
3Pain (Aches)
01/2022 - 11/2000
3Hypertension (High Blood Pressure)
01/2022 - 05/2015
3Glioblastoma (Glioblastoma Multiforme)
06/2020 - 04/2002
3Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
05/2020 - 08/2001
3Squamous Cell Carcinoma of Head and Neck
05/2020 - 04/2014
3Adenocarcinoma
02/2020 - 03/2000
3Autoimmune Diseases (Autoimmune Disease)
10/2019 - 12/2012
3Adenocarcinoma of Lung
01/2018 - 01/2000
3Colorectal Neoplasms (Colorectal Cancer)
01/2018 - 02/2014
3Reperfusion Injury
01/2018 - 01/2012
3Pneumonia (Pneumonitis)
10/2017 - 07/2015
3Residual Neoplasm
10/2017 - 08/2013
3Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal)
01/2017 - 10/2013
3Acne Vulgaris
07/2016 - 01/2001
3Hyperoxia
05/2016 - 01/2014
3Lung Injury
05/2016 - 01/2014
3Schizophrenia (Dementia Praecox)
01/2016 - 06/2000
3Sleep Deprivation
01/2016 - 01/2000
3Pemphigus (Pemphigus Vulgaris)
01/2015 - 11/2000
3Hepatocellular Carcinoma (Hepatoma)
11/2014 - 01/2014
3Ischemia
07/2014 - 01/2012
3Prostatic Neoplasms (Prostate Cancer)
09/2012 - 02/2001
3Encephalitis (Encephalitis, Rasmussen)
12/2002 - 09/2000
3Giant Cell Carcinoma
01/2001 - 10/2000
2Burns
05/2022 - 12/2000
2Nausea
01/2022 - 11/2015
2Bone Resorption
12/2021 - 01/2018
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
11/2021 - 01/2018
2Erythema
05/2020 - 07/2016
2Aortic Dissection
02/2020 - 08/2016

Drug/Important Bio-Agent (IBA)

15Proteins (Proteins, Gene)FDA Link
01/2020 - 11/2000
9Messenger RNA (mRNA)IBA
01/2018 - 01/2000
9Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2018 - 10/2000
8Glucose (Dextrose)FDA LinkGeneric
01/2018 - 11/2007
7CytokinesIBA
10/2020 - 05/2001
7Pharmaceutical PreparationsIBA
03/2018 - 11/2000
6Biological ProductsIBA
10/2020 - 01/2000
6Long Noncoding RNAIBA
01/2020 - 09/2015
5Reactive Oxygen Species (Oxygen Radicals)IBA
09/2017 - 01/2012
4InterleukinsIBA
10/2020 - 10/2014
4Triglycerides (Triacylglycerol)IBA
06/2020 - 11/2007
4Monoclonal AntibodiesIBA
05/2020 - 12/2001
4EnzymesIBA
05/2020 - 01/2015
4ErbB Receptors (EGF Receptor)IBA
02/2020 - 04/2002
4Phosphotransferases (Kinase)IBA
01/2020 - 06/2001
4Interleukin-10 (Interleukin 10)IBA
12/2018 - 12/2000
4ChemokinesIBA
12/2018 - 09/2000
4Anti-Bacterial Agents (Antibiotics)IBA
02/2018 - 04/2001
4RNA (Ribonucleic Acid)IBA
01/2018 - 12/2001
4Oxygen (Dioxygen)IBA
01/2018 - 01/2014
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
08/2016 - 03/2001
4DNA (Deoxyribonucleic Acid)IBA
06/2013 - 04/2000
3MicroRNAs (MicroRNA)IBA
08/2019 - 09/2017
3Interleukin-6 (Interleukin 6)IBA
07/2019 - 04/2015
3Blood Glucose (Blood Sugar)IBA
01/2019 - 06/2012
3InterferonsIBA
01/2019 - 01/2015
3CholesterolIBA
01/2019 - 02/2014
3LigandsIBA
08/2016 - 01/2000
3Insulin (Novolin)FDA Link
01/2016 - 08/2011
3AntioxidantsIBA
01/2016 - 04/2014
3Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
10/2014 - 02/2001
3XenonIBA
09/2014 - 08/2010
3Complementary DNA (cDNA)IBA
12/2001 - 10/2000
2Lactic Acid (Lactate)FDA LinkGeneric
12/2021 - 03/2017
2Cisplatin (Platino)FDA LinkGeneric
11/2021 - 09/2017
2Indicators and Reagents (Reagents)IBA
10/2020 - 01/2005
2CollagenIBA
10/2020 - 05/2015
2Immunosuppressive Agents (Immunosuppressants)IBA
10/2020 - 02/2013
2IronIBA
07/2020 - 01/2014
2ImmunosorbentsIBA
05/2020 - 09/2018
2Anaplastic Lymphoma KinaseIBA
02/2020 - 05/2015

Therapy/Procedure

21Therapeutics
10/2020 - 12/2000
9Drug Therapy (Chemotherapy)
11/2021 - 02/2000
4Radiotherapy
11/2021 - 04/2014
3Stents
04/2019 - 08/2010
3Aftercare (After-Treatment)
05/2015 - 01/2000
2Punctures
01/2022 - 12/2019
2Induction Chemotherapy
11/2021 - 04/2014
2Chemoradiotherapy
11/2021 - 01/2012